---
title: "Enzon Announces Reverse Stock Split | ENZN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280318791.md"
description: "Enzon Announces Reverse Stock Split | ENZN Stock News"
datetime: "2026-03-24T04:45:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280318791.md)
  - [en](https://longbridge.com/en/news/280318791.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280318791.md)
generator: "portal-rs"
---

# Enzon Announces Reverse Stock Split | ENZN Stock News

Enzon Announces Reverse Stock Split | ENZN Stock News

### Related Stocks

- [ENZB.US](https://longbridge.com/en/quote/ENZB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ENZ.US](https://longbridge.com/en/quote/ENZ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [U.S. kindergarten vaccine coverage falls, CDC says](https://longbridge.com/en/news/296136711.md)
- [LIVE MARKETS-BofA clients flock to tech stocks](https://longbridge.com/en/news/296383193.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**